ATE478839T1 - Verfahren zur herstellung von kristallinem dexloxiglumid - Google Patents

Verfahren zur herstellung von kristallinem dexloxiglumid

Info

Publication number
ATE478839T1
ATE478839T1 AT04743871T AT04743871T ATE478839T1 AT E478839 T1 ATE478839 T1 AT E478839T1 AT 04743871 T AT04743871 T AT 04743871T AT 04743871 T AT04743871 T AT 04743871T AT E478839 T1 ATE478839 T1 AT E478839T1
Authority
AT
Austria
Prior art keywords
dexloxiglumide
producing crystalline
crystalline dexloxiglumide
morphological
favor
Prior art date
Application number
AT04743871T
Other languages
German (de)
English (en)
Inventor
Francesco Makovec
Lucio Rovati
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE478839T1 publication Critical patent/ATE478839T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04743871T 2003-06-23 2004-06-21 Verfahren zur herstellung von kristallinem dexloxiglumid ATE478839T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000474A ITTO20030474A1 (it) 2003-06-23 2003-06-23 Procedimento per la preparazione di dexloxiglumide
PCT/IB2004/002208 WO2004113271A2 (en) 2003-06-23 2004-06-21 A method for the preparation of crystalline dexloxiglumide

Publications (1)

Publication Number Publication Date
ATE478839T1 true ATE478839T1 (de) 2010-09-15

Family

ID=33524063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743871T ATE478839T1 (de) 2003-06-23 2004-06-21 Verfahren zur herstellung von kristallinem dexloxiglumid

Country Status (12)

Country Link
US (1) US7662994B2 (https=)
EP (1) EP1646607B1 (https=)
JP (1) JP5197955B2 (https=)
AT (1) ATE478839T1 (https=)
AU (1) AU2004249526B2 (https=)
CA (1) CA2529018C (https=)
DE (1) DE602004028830D1 (https=)
DK (1) DK1646607T3 (https=)
ES (1) ES2351662T3 (https=)
IT (1) ITTO20030474A1 (https=)
PT (1) PT1646607E (https=)
WO (1) WO2004113271A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863330B2 (en) * 2006-06-14 2011-01-04 Rottapharm S.P.A. Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217123B (it) 1987-02-05 1990-03-14 Rotta Research Lab Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
DE69112917T2 (de) * 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
US7122083B2 (en) * 2002-04-02 2006-10-17 E. I. Du Pont De Nemours And Company Apparatus and process used in growing crystals

Also Published As

Publication number Publication date
HK1089750A1 (en) 2006-12-08
EP1646607A2 (en) 2006-04-19
EP1646607B1 (en) 2010-08-25
ES2351662T3 (es) 2011-02-09
WO2004113271A2 (en) 2004-12-29
AU2004249526A1 (en) 2004-12-29
CA2529018A1 (en) 2004-12-29
AU2004249526B2 (en) 2011-02-24
PT1646607E (pt) 2010-10-12
DE602004028830D1 (de) 2010-10-07
WO2004113271A3 (en) 2005-01-27
CA2529018C (en) 2013-05-28
US7662994B2 (en) 2010-02-16
WO2004113271A8 (en) 2005-05-06
US20060154987A1 (en) 2006-07-13
ITTO20030474A1 (it) 2004-12-24
JP2007521253A (ja) 2007-08-02
DK1646607T3 (da) 2010-11-22
JP5197955B2 (ja) 2013-05-15

Similar Documents

Publication Publication Date Title
HRP20050735B1 (hr) Dihidropteridinoni, metoda za njihovu proizvodnju i upotrebu u obliku lijekova
DE60201480D1 (de) Verfahren zur Herstellung von hochreinem Xylylendiamin
CO5611065A2 (es) Difluorometiltiazolilcarboxanilidas
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE420167T1 (de) Reinigungsverfahren für plasmid-dna
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
BR0215709A (pt) Processo para a preparação de cefdinir
SE0302029D0 (sv) Novel process
ATE442355T1 (de) Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung
DE602005020185D1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
ATE478839T1 (de) Verfahren zur herstellung von kristallinem dexloxiglumid
EP1485498A4 (en) SYNTHESIS OF SYNTHESES FOR THE MANUFACTURE OF BIOACTIVE COMPOUNDS
DE602005005218D1 (de) Kristalline form von cefdinir-ammoniumsalz als zwischenprodukt für die herstellung von reinem cefdinir
ATE388949T1 (de) Verfahren zur herstellung von z-flupentixol
DE60325390D1 (de) Verfahren zur herstellung von zwischenprodukten
ATE553080T1 (de) Verkürztes verfahren zur herstellung von l- lobelin
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
ATE466010T1 (de) Verfahren zur herstellung von candesartan
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
BRPI0409039A (pt) processo para a preparação de um produto de reação, processos para a preparação de uma composição farmacêutica, agroquìmica, de limpeza e de tinta, e processo para a preparação de um refrigerante
DE60310734D1 (de) Verfahren zur Herstellung von Nateglinidin der B-Form
ATE502045T1 (de) Verfahren zur herstellung von perindoprilerbumin
ECSP066382A (es) Proceso de purificación

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1646607

Country of ref document: EP